Pharmagen, Inc.
PHRX
$0.00
$0.000.00%
OTC PK
| 03/31/2014 | 12/31/2013 | 09/30/2013 | 06/30/2013 | 03/31/2013 | |
|---|---|---|---|---|---|
| Net Income | -712.60K | -2.31M | -1.35M | -1.50M | -841.80K |
| Total Depreciation and Amortization | 30.20K | 33.60K | 26.70K | 20.40K | 18.60K |
| Total Amortization of Deferred Charges | 540.60K | 731.00K | 636.60K | 621.10K | 578.70K |
| Total Other Non-Cash Items | -314.40K | 619.20K | -21.60K | 475.70K | -117.40K |
| Change in Net Operating Assets | 504.60K | 894.90K | 581.70K | 8.10K | 201.30K |
| Cash from Operations | 48.40K | -31.90K | -123.90K | -375.70K | -160.60K |
| Capital Expenditure | -62.20K | -29.00K | -7.70K | -3.70K | -16.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -62.20K | -29.00K | -7.70K | -3.70K | -16.30K |
| Total Debt Issued | -- | 0.00 | 17.50K | 178.80K | 559.20K |
| Total Debt Repaid | -47.50K | -26.40K | 97.40K | -241.30K | -22.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 100.00K | 125.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -35.50K |
| Cash from Financing | 52.50K | 98.60K | 114.90K | -62.50K | 501.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.70K | 37.60K | -16.70K | -441.90K | 324.40K |